Renal Flashcards

1
Q

Pronephros

A

Early embryologic kidney (Week 4)–> degenerates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mesonephros

A

Interim kidney for 1st trimester

- Contributes to male genitalia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Metanephros

A

Permanent kidney structure; appears in 5th week
- Nephrogenesis until 32-36 weeks gestation

Structures within metanephros:

  • Ureteric bud
  • Metanephric mesenchyme (mesoderm)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Intermediate mesoderm

A

Forms urogenital ridge–> nephrogenic cord–> mesonephros:

  • Wolffian duct in males
  • Gartner’s ducts in females
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ureteric bud

A
Caudal end of mesonephros; canalized by week 10
Collecting system:
- Collecting duct
- Major/minor calyxes
- Renal pelvis
- Ureters
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Metanephric mesoderm

A

Kidney structures:

  • Glomerulus
  • Bowman’s space
  • Proximal tubule
  • Loop of Henle
  • Distal and collecting tubule

** formed through interaction/induction with ureteric bud

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ureteropelvic junction

A

Last part of kidney to canalize–> most common site of obstruction (hydronephrosis) in fetus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Potter’s syndrome

A

Oligohydramnios–> compressed fetus–> limb/facial deformities, pulmonary hypoplasia (death)

can’t Pee–> Potters

Causes:

  • ARPKD
  • Posterior urethral valves
  • Bilateral renal agenesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Horseshoe kidney

A

Inferior poles of kidneys fuse
- Ascend–> trapped under inferior mesenteric artery

Normal function
* Associated with Turner’s syndrome (46XO)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Multicystic dysplastic kidney

A

Abnormal interaction between ureteric bud and metanephros–> nonfunctional kidney (cysts and connective tissue)
- Unilateral= asymptomatic, contralateral kidney hypertrophies to compensate

Prenatal diagnosis with ultrasound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Fluid balance

A

60% total body water

  • 2/3 (40% total) Intracellular (ICF)
  • 1/3 (20% total) extracellular (ECF): 1/4 plasma, 3/4 interstitial

Plasma volume= measured by radiolabeled albumin
ECF= measured by inulin (freely filtered, fully cleared)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Glomerular filtration barrier

A

Vessel: fenestrated capillary endothelium (size barrier)
Glomerulus:
- Basement membrane (fused) with heparin sulfate= negative charge barrier
- Epithelial layer= podocyte foot processes

** charge barrier lost in nephrotic syndrome–> albuminuria, hypoproteinemia, generalized edema, hyperlipidemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Renal clearance

A

Clearance (x)= Urine[x]*Urine flow (V)/ Plasma[x]
Cx=UxV/Px

Cx < GFR: reabsorption
Cx > GFR: secretion
Cx = GFR: no net secretion or reabsorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

GFR

A

Inulin clearance used to calculate GFR= completely cleared

GFR= U[inulin]*V/P[inulin]= C[inulin]

** Creatinine clearance is approximate measurement of GFR (slightly overestimates as renal tubules secrete):
Creatinine= Non-protein waste product of skeletal muscle metabolism

Clearance= 15-25 mg/kg/day= proportional to muscle mass; Serum concentration dependent on:

  • Excretion (glomerular filtration)
  • Secretion into lumen

Changes in creatinine excretion have hyperbolic relationship with GFR:
- jump from 1 to 2 mg/dL–> 50% loss of nephrons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Effective renal plasma flow

A

Estimate using PAH clearance: filtered and actively secreted in proximal tubule
- All entering kidney–> excreted

ERPF= U[PAH] * V/P[PAH}
** underestimates by ~10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Filtration

A

Filtration fraction= GFR/RPF

  • Normal = 20%
  • Filtered load= GFR * plasma concentration
  • Prostaglandins dilate Afferent arteriole–> increased RPF, GFR–> constant FF)
  • Blocked by NSAIDs
  • Angiotensin II constricts Efferent arteriole–> decreased RPF, increased GFR–> increased FF
  • Blocked by ACE-I
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Glucose clearance

A

Completely reabsorbed in proximal tubule: Na+/glucose cotransport

  • 160 mg/dL–> glucosuria
  • 350 mg/dL–> transporters fully saturated (Tm)

Pregnancy: decreased reabsorption of glucose, amino acids–> glucosuria, aminoaciduria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Amino acid clearance

A

Reabsorbed in proximal tubule:
Na+-dependent transporters

Hartnup’s= deficiency of neutral aa (tryptophan) transporter–> pellagra

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Urea excretion

A

Freely filtered at glomerulus

  • Passively reabsorbed in proximal tubule, inner medullary collecting duct
  • Passively secreted by thin loop of Henle

10-70% excreted depending on urinary flow, concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

PTH in kidney

A

Acts on interstitial side of tubules

Proximal tubule: inhibits Na/Phosphate cotransporter–> excrete phosphate
- enhances activity of enzyme (1-alpha-hydroxylase) that converts 25-OH to 1,25-OH2 Vit D

DCT: increases Ca+2/Na+ exchange–> increased Ca+2 reabosorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Angiotensin II

A

Maintains blood volume and BP

Within kidney:

  1. Constricts efferent arteriole
  2. PCT: stimulates Na+/H+ exchange on luminal side–> increased Na+, H2O, HCO3- reabsorption (compensatory Na+ resorption with water vs ADH)
    * Contraction alkalosis (dehydrated–> more ATII–> more bicarb resorption)

Adrenal gland:
- Synthesis of aldosterone

Vasculature:
- AT1 receptors on smooth muscle–> vasoconstriction–> increased BP

Posterior pituitary:
- ADH secretion–> H2O absorption via aquaporin in medullary collecting duct

Hypothalamus:
- Thirst

Cardiac:
- Limits reflex bradycardia that normally accompanies increased BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Aldosterone

A

decreased blood volume–> renin–> angiotensin II production–> Aldosterone in adrenal gland
- Also secreted in response to elevated [K+]

Cortical Collecting duct:

  • Mineralocorticoid receptor–> insert Na+ channel on luminal side–> increase Na+, water resoprtion
  • Na+/K+ pump insertion on interstitial side
  • upregulates K+ channels, intercalated H+ channels–> K+ and H+ excreted–> can cause metabolic alkalosis

** Directly blocked from receptor by spironolactone; effects blocked by amiloride, triamterine (K+-sparing diuretics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

ADH

A

decreased blood volume–> renin–> angiotensin II production–> ADH in posterior pituitary

Regulates osmolarity
Responds to low blood volume (overrides osmolarity)
Collecting tubule
- Acts on V2 receptor
- Inserts aquaporin channel on luminal side

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

ANP

A

Released from atria in response to increased blood volume

  • “Checks” RAAS
  • Relaxes vascular smooth muscle: increased cGMP–> increased GFR–> decreased renin–> Na+ and H2O loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Juxtaglomerular apparatus

A

JG cells= smooth muscle cells of afferent arteriole
- Secrete renin when renal BP low

Macula densa= DCT NaCl sensor
- Induce JG cells to secrete renin in response to low NaCl in DCT

Renin converts Angiotensinogen (liver) to angiotensin I–> lungs (ACE)–> angiotensin II

+ Increased sympathetic tone (Beta-1)
** Beta-blockers (Beta-1 selective, like metoprolol) can decrease BP–> inhibiting B1 receptors of JGA–> decreased renin release

26
Q

EPO

A

Erythropoietin

- Released by interstitial cells in peritubular capillary bed in response to hypoxia

27
Q

1,25-OH2 Vitamin D

A

Converted by PCT cells from 25-OH to 1,25-OH2 (active form)
- PTH enhances activity of enzyme (1-alpha-hydroxylase)

** PTH secreted in response to low plasma [Ca+2] or [vit D] or high plasma [Phosphate]

28
Q

Potassium shift out of cell

A

DO Insulin LAB work:

  • Digitalis
  • hyperOsmolarity
  • Insulin deficiency
  • Lysis of cells
  • Acidosis
  • Beta-adrenergic antagonist
29
Q

Na+ balance

A

Low serum [Na+]
- Nausea, malaise, stupor, coma

High serum [Na+]
- Irritability, stupor, coma

30
Q

K+ balance

A

Low serum [K+]

  • ECG: U waves, Flattened T waves
  • Arrhythmias, muscle weakness

High serum [K+]

  • Wide QRS, peaked T waves
  • Arrhythmias, muscle weakness
31
Q

Ca+2 balance

A

Low [Ca+2]
- Tetany, seizures

High [Ca+2]
- Stones, bones, groans, moans

32
Q

Mg+2 balance

A

Low [Mg+2]
- tetany, arrhythmias

High [Mg+2]
- decreased DTRs, lethargy, bradycardia, hypotension, cardiac arrest, hypocalcemia

33
Q

Respiratory compensation for metabolic acidosis

A

Winter’s formula:

PCO2= 1.5 (HCO3-) + 8 +/-2

34
Q

Anion Gap

A

Check with metabolic acidosis:
Na+ - (Cl- + HCO3-)

Increased:
MUDPILES
- Methanol
- Uremia
- Diabetic ketoacidosis
- Propylene glycol
- Iron tablets/INH
- Lactic acidosis
- Ethylene glycol
- Salicylates
Normal:
HARDASS
- Hyperalimentation
- Addison's disease
- Renal tubular acidosis
- Diarrhea
- Acetazolamide
- Spironolactone
- Saline infusion
35
Q

Distal Renal tubular acidosis

A

Type 1 Renal Tubular Acidosis:
Failure of distal alpha intercalated cells to excrete H+

Leads to:
- Elevated blood H+
- Inability to acidify urine (pH > 5.3)–> increased risk of calcium phosphate stones
- Elevated Chloride
- Hypokalemia
- Bone reabsorption (Rickets in kids, osteomalacia in adults)
Hyperchloremic non-anion gap acidosis

36
Q

Proximal renal tubular acidosis

A

Type 2 Renal Tubular Acidosis
Failure of proximal tubular cells to reabsorb bicarb

Leads to:

  • Elevated blood H+
  • CAN acidify urine (excrete H+)- ph < 5.3
  • Hypokalemia
  • Increased rick for hyposphatemic rickets

Seen in Fanconi’s anemia

37
Q

Hyperkalemic renal tubular acidosis

A

Type 4 RTA
Collecting tubule not responsive to aldosterone or hypoaldeosteronism
–> HYPERkalamia–> impaired ammoniagensis in PCT
- Decreased buffering, decreased urine pH

38
Q

Alport syndrome

A

Type IV collagen defect
- type IV collagen= basement membrane, basal lamina of kidneys, ears, eyes

X-linked recessive (boys)

Symptoms:

  • Progressive nephritis
  • Deafness
  • Ocular disturbances
39
Q

Calcium stones

A

Calcium oxalate= due to hypercalciuria

  • Acidic urine (low pH)
  • Calcium oxalate stones are hard and dark
  • Presentation: hypercalciuria and normocalcemia
  • Urinalysis: calcium oxalate crystals are colorless tetrahedra (envelope shape), oval or dumbbell shapes; polarizable
    • seen in ethylene glycol poisoning (antifreeze), Vitamin C overuse, Crohn’s disease (low calcium reabsorption–> oxalate crystal formation)

Calcium phosphate: due to hypercalciuria
- increased pH causes precipitation

Prevention: thiazides, citrate

40
Q

Struvite stones

A

Magnesium ammonium phosphate (15% of stones)

  • Due to urea-splitting bacteria (Proteus, Staphylococcus, Providencia)
  • Alkaline urine (high pH)
  • Triple phosphate crystals in urinalysis are colorless, rectangles or coffin lids shaped
  • Staghorn calculi (nidus for UTIs)
41
Q

Uric acid stones

A

Due to hyperuricemia (6% of stones)

  • precipitate in collecting duct @ low pH
  • RadiolUcent: can see on CT, ultrasound
  • Acidic urine (low pH)
  • Rhomboid crystals

Hyperuricemia also seen in high cell turnover states (leukemia)

Tx: alkalinize urine

42
Q

Cystine stones

A

Due to genetic defects in cystine transport

  • Autosomal recessive
  • Yellow-brown radiopaque stones
  • acidic urine (low pH)
  • Hexagonal crystals

** Sodium nitroprusside testing–> urine turns purple after 2-10 minutes

Tx: alkalinize urine

43
Q

Renal papillary necrosis

A

Sloughing renal papillae:

  • Presentation: gross hematuria, acute, colicky flank pain (ureteral obstruction from sloughed papillae), proteinuria; recent infection/immune stimulus
  • Associated with: DM, acute pyelonephritis, chronic phenacetin use (acetaminophen), NSAID use, sickle cell anemia/trait

Histo: coagulative infarct necrosis with preserved tubule outline
- Scars develop on cortical surface (fibrous depressions replace inflammatory foci)

44
Q

Prerenal azotemia

A

Elevated nitrogen levels in blood NOT due to kidney damage

  • Renal blood flow decreased–> decreased GFR–> decreased clearance of metabolites
  • Kidney is intact and cells are not damaged
  • Kidney avidly reabsorbs salt and water to try and preserve intravascular blood volume and renal blood flow.

Features:

  • History of volume depletion
  • Exam consistent with volume depletion
  • Fractional Excretion of Na (FENa) < 1 %
  • Urine Na < 20 mEq/L (low if kidney is Na avid, tubules intact)
  • Urine Osm > 500 mOsm/L
  • Increased BUN/Creatinine Ratio
  • Bland urinalysis
  • Ultimate Test: Give Fluid
  • If immediate improvement, then it’s pre-renal
45
Q

Intrinsic renal failure

A

Causes:

  • Acute tubular necrosis
  • Ischemia/toxins
  • Acute glomerulonephritis (RPGN); rarer

Pathogenesis:

  1. Patchy necrosis–> debris obstructs tubule
  2. fluid backflow–> decreased GFR

Urine sediment:

  • epithelial/granular casts on urinalysis
  • Casts= mucoprotein secreted by renal tubule cells
  • -> decreased GFR–> increased accumulation of casts

Urine lytes:

  • Na > 40 mEq/L or FENa > 2%
  • Serum BUN/Cr < 15
46
Q

Postrenal azotemia

A
In patients with two functioning kidneys, both need to be effected to produce significant renal failure
Causes:
- Urethral obstruction – most common
- Obstruction of a solitary kidney
- Bilateral ureteral obstruction

Causes:

  • Urethral obstruction
  • Bladder neck obstruction (prostatic hypertrophy, bladder carcinoma, bladder infecion)
  • Bilateral ureter obstruction:
    1. Intraureteral:
  • Sulfonamide, uric acid crystals, blood clots/stones
    2. Extraureteral:
  • tumor (cervix, prostate, endometriosis)
  • Retroperitoneal fibrosis
  • Ureteral ligation/edema due to pelvic operation

Features:

  • low urine osmolality
  • high urine Na+
  • FENa > 2%
  • Serum BUN/creatinine > 15
47
Q

Renal Failure consequences

A

Can’t make urine (oliguria) or excrete nitrogenous waste
Acute loss of kidney function
- Typically connotes acute drop in GFR

Multiple definitions of this, typically based on changes in:

  • Serum Creatinine
  • Oliguria: <50cc UOP/day
  • Azotemia: elevated blood urea nitrogen (BUN ) without symptoms of uremia
  • Uremia: buildup of toxins that are cleared by the kidney. Most of these toxins are unknown. (Nausea, anorexia, pericarditis, asterixis, encephalopathy, platelet dysfunction)
    • An elevated Urea level alone is NOT sufficient to diagnose uremia
  • Na/H2O retention (CHF, pulmonary edema, HTN)
  • Hyperkalemia
  • Metabolic acidosis
  • Anemia (failure of interstitial cells to synthesize EPO)
  • Renal osteodystrophy
  • Dyslipidemia (increased TG)
  • Growth retardation, developmental delay in children
48
Q

Renal osteodystrophy

A
  • High PTH due to: hypocalcemia, hyperphosphetemia, low calcitriol level,
  • Low calcium due to low calcitriol level
  • High phosphate due to decreased GFR
  • Result of increased PTH: too rapid bone turnover, abnormal bone (woven vs. trabecular)
49
Q

Mannitol

A

Osmotic diuretic

Not reabsorbed, causing water to be retained initially, then diuresis

Site of action:

  • Proximal tubule: decreased Na reabsorption by osmotic gradient–> increased urine volume
  • Descending loop of Henle: increased medullary blood flow, inhibit reabsorption of water
  • Collecting duct: opposes action of ADH

Clinical:

  • Prevents acute renal failure after severe trauma, complicated surgical procedures (hemolysis, rhabdomyolysis)
  • Drug overdose: Toxin excretion
  • Reduces intracranial, intraocular pressure–> fluid (not Na) leaves cells
  • Does not increase Na excretion (only water)
  • Must be given IV (only effects colon if given orally)

AEs:

  • PULMONARY EDEMA (contraindicated in anuria, CHF)
  • Rapidly distributes to ECF–> extracts water from cells
  • Causes acute increase in ECF/hyponatremia (can’t use in CHF, pulmonary edema)
  • N/V, headache
  • Severe dehydration, hypernatremia
  • Hyperkalemia
50
Q

Acetazolamide

A

Carbonic anhydrase inhibitor

Site of action: proximal tubule

MOA:

  • Inhibits carbonic anhydrase
  • Decreases sodium bicarbonate reabsorption
  • Cause bicarbonate diuresis (up to 85%) that may lead to metabolic acidosis
  • Over time (several days), effectiveness decreases–> soon increase Na reabsorption (thus reversing diuresis)

Use: metabolic alkalosis (alkalinizes urine)

  • Induces hyperchloremic metabolic acidosis after excessive use of other diuretics
  • Prophylax acute mountain sickness (decreases CSF formation, pH–> increase minute ventilation–> decrease symptoms)
  • Glaucoma (decreases rate of aqueous humor formation–> decreased IOP)
  • Pseudotumor cerebri

AEs:

  • Metabolic acidosis (decreased bicarb reabsorption)
  • Phosphaturia, hypercalciuria (can cause calcium stone formation)
  • Potassium wasting
  • Toxicity: drowsiness/fatigue (CNS carbonic anhydrase inhibition), parasthesis, avoid in liver disease (increases ammonia–> hepatic encephalopathy)
51
Q

Loop diuretics

A

Furosemide, Bumetanide, Ethacrynic acid

Site of action: cortical and medullary TAL of loop of Henle

MOA: inhibits Na+-K+-2Cl- transporter

Clinical:

  • Rapid onset of action (first line in pulmonary edema)
  • Stimulates prostaglandin synthesis in lung, kidneys (NSAIDs–> decreased prostaglandins–> decreased diuresis)
  • CHF (decrease ECF volume)
  • Excretion of: K+, Mg+2 and Ca+2 (Ca reabsorbed later in DCT, but can be used in hypercalcemia)
  • Nephrotic syndrome

Side effects:

  • OTOTOXICITY (esp, with aminoglycosides, salicylates, cisplatin)
  • hypokalemia, hypomagnesemia
  • hyperuricemia (gouty attack)
  • decreased paracellular Ca+2 reabsorption–> hypocalcemia (+ calciuria)
  • hypochloremic metabolic alkalosis:
    1. increased excretion of H+ in low K+ state in Cortical collecting tubule
    2. Volume contraction–> ATII increase–> Na/H exchange in PCT–> increased bicarb reabsorption (contraction alkalosis)
  • Cross-reactivity with sulfonamide allergy
  • Dehydration
  • Increased LDL, triglycerides, decreased HDL
52
Q

Hydrochlorothiazide

A

Thiazide diuretics

Site of action: early distal convoluted tubule

MOA: inhibits luminal co-transport of Na, Cl
- Contraction of ECF volume–> decrease in CO–> decrease peripheral vascular resistance

Clinical use:

  • Use in HTN, mild CHF
  • Idiopathic hypercalciuria
  • Nephrogenic DI
  • Renal stones (decreases Ca+ excretion)

AEs:

  • Avoid in low GFR
  • “Ceiling diuretics”: increasing dose does not promote further diuresis
  • hypokalemic metabolic alkalosis
  • hyponatremia
  • hypomagnesemia
  • Hypercalcemia
  • Hyperuricemia (gouty attack)
  • Sulfa allergy interaction: photosensitivity, generalized dermatitis (rare)
  • Hyperglycemia (impair pancreatic insulin release, tissue utilization of glucose)
  • Hyperlipidemia
  • Volume depletion
53
Q

Spironolactone, Eplerenone

A

Potassium-sparing diuretic

MOA: competitive antagonist of aldosterone receptors on collecting tubule (Na-H exchanger)

SIte of action:
- Cortical collecting tubule

Clinical:

  • Most effective in primary/secondary hyperaldosteronism (Conn syndrome) - prevents binding of aldosterone to its receptor
  • Secondary hyperaldosteronism seen in: CHF, hepatic cirrhosis, nephrotic syndrome
  • Ascites
  • HTN
  • Loop/thiazide-induced hypokalemia

AEs:

  • Hyperkalemia (if not on another diuretic)–> can lead to acidosis (body cells exchange K+ for H+)
  • Hyperchloremic metabolic acidosis= blocks collecting duct Na-H exchange (aldosterone receptor)–> can’t excrete H+
  • Endocrine abnormalities: gynecomastia, hirsutism, impotence, benign prostatic hyperplasia, menstrual irregularities
54
Q

Triamterene, amiloride

A

Postassium-sparing diuretic

MOA: interferes with Na+ influx thru epithelial Na ion channels in luminal membrane (Na-H exchanger in collecting duct)
- K+ secretion coupled with Na+ entry (therefore spare K+ secretion by blocking Na entry)

Clinical use:

  • HTN
  • Loop/thiazide-induced hypokalemia

AEs:

  • Hyperkalemia (if not on another diuretic)–> can lead to acidosis
  • Hyperchloremic metabolic acidosis= blocks collecting duct Na-H exchange (aldosterone receptor)–> can’t excrete H+
55
Q

ACE-I

A

Captopril, enalapril, lisinopril

MOA: inhibits ACE–> decreased angiotensin II–> decreased GFR (prevent constriction of efferent arterioles)

  • Increased bradykinin= vasodilator
  • Renin increased due to lack of feeback inhibition
  • ARBs work similarly but do not increase bradykinin

Use:

  • HTN
  • CHF
  • Proteinuria, diabetic renal disease
  • Prevents heart remodeling due to chronic HTN

Tox:

  • Cough
  • Angioedema
  • Teratogen (fetal renal malformations)
  • Creatinine kinase (deceased GFR)
  • Hyperkalemia
  • Hypotension
    • avoid in bilateral renal artery stenosis–> further deceased GFR–> renal failure
  • Stop thiazides before initiating ACE-I due to 1st dose hypotension (avoid non-selective beta-blocker with ACE-I–> increased K+)
56
Q

ARB

A

-sartans

MOA:

  • Bind AT-1 receptors (site of angiotensin II binding)–> decreased aldosterone
  • Increased renin, angiotensin I and II (no negative feeback)

Use:

  • HTN
  • CHF
  • Proteinuria, diabetic renal disease
  • Prevents heart remodeling due to chronic HTN

Tox:

  • Teratogen (fetal renal malformations)
  • Creatinine kinase (deceased GFR)
  • Hyperkalemia
  • Hypotension
    • avoid in bilateral renal artery stenosis–> further deceased GFR–> renal failure
  • Stop thiazides before initiating ARB due to 1st dose hypotension (avoid non-selective beta-blocker with ARB–> increased K+)
57
Q

Diabetic nephropathy

A
  • Microalbuminuria = 30-300 mg albumin daily
  • Overt nephropathy > 300mg/day
  • nephrotic syndrome approximately 3,000 mg/day (3g/day)
    • Routine urinalysis can’t detect microalbuminuria
    • Microalbunuria portends nephropathy
58
Q

Chronic interstitial nepritis

A

Prolonged analgesic use (NSAIDs)
- Patchy interstitial inflammation–> fibrosis, necrosis, scarring of papillae, distorted calices architecture, tubular atrophy

59
Q

Workup of metabolic alkalosis

A
  1. Loss of H+ ions from body: vomiting, NG suction–> decreased serum Cl- –> decreased urinary Cl-
  2. Thiazide/loop diuretics–> Na+ loss–> Cl- follows Na+–> contraction alkalosis (Cl- responsive)
    - Corrected by saline administration
  3. Hyperaldosteronism (Conn Syndrome): Increases Na+ reabsorption–> K, Cl, H+ losses–> increased HCO3- (metabolic alkalosis)
    - Increased urine Cl-
    - Adinistration of saline does NOT correct condition
60
Q

Casts in urine

A

RBC: glomerulonephritis, ischemia, malignant HTN

WBC: Tubulointerstitial inflammation, acute pyelonephritis, transplant rejection

Fatty casts (oval fat bodies): nephrotic syndrome

  • Microalbuminuria= < 300 mg/day
  • Overt nephropathy= > 300 mg/day
  • Nephrotic syndrome= 3+ g/day
    • Nephrotic syndrome= hyperlipidemia, fatty casts, edema; associated with thromboembolism d/t ATIII loss in urine, infections d/t Ig loss

Granular casts (muddy brown)= acute tubular necrosis

Eosinophils in urine= acute interstitial nephritis (due to meds)

Waxy casts= advanced renal disease/chronic renal failure

Hyaline casts= normal, may be seen in low flow rates d/t Tamm-Horsfall glycoprotein accumulation

Cholesterol crystals in arterioles (not urine)= atherosclerotic embolization (following angioplasty)–> renal arterial damage